The Market

A Digital Therapeutic For Alzheimer's & Dementia Patients

ReminX has the ability to combine the mass market scalability of a consumer focused technology with a proven and well known therapy to create a first-in-class Digital Therapeutic addressing one of the largest unmet medical needs.

We will be conducting a Proof of Concept clinical trial to generate data supporting the product’s ability to measurably impact the lives of these patients.

Facts on Alzheimer’s & Dementia

The number of Americans living with Alzheimer’s disease is growing — and growing fast.

  • An estimated 5.4 million Americans of all ages have Alzheimer’s disease in 2016
  • One in nine people age 65 and older has Alzheimer’s disease
  • Alzheimer’s is the only disease among the top 10 causes of death in America that cannot be prevented, cured or even slowed


  • ReminX is built on the understanding that although families deeply love their family members who are residents, most members of the family simply do not have the time to create scrapbooks, schedule a Facetime call, or sometimes-even visit. ReminX, however, mirrors the actions people already take in their day to day lives: texting photos, leaving voicemails, and flipping through their social media feeds
  • We believe that if we can show through a clinical trial that by a family member engaging just 2-3 minutes a week we can make the lives of the resident’s measurably better it will be enough of a priority to fit into their lives
  • ReminX will be measuring the reduction of anxiety for the Caregivers as well as the patients
Alzheimer's takes a devastating toll – not just on those with the disease, but also on entire families

Senior Living

Dthera Within Senior Living Facilities

A significant advantage Dthera has is an already granted patent that covers the senior living market in a broad and powerful way. Dthera acquired this patent by bringing in the core aspects of Seniors In Touch, one of the first technology innovators in the senior living space.

  • There are 1.4 million people in nursing homes and another 700,000 in residential care communities but more than 50% of residents in assisted living have some form of dementia or cognitive impairment
  • By seamlessly fitting into family’s lives ReminX can engage family members into not only hearing the stories from their parents and grandparents, but also creating new stories for the family members that are within the facilities to experience and enjoy
  • By increasing family engagement, not only do the residents lives meaningfully improve, but the families themselves are now empowered in knowing that they are directly impacting their loved ones
The Senior Living Space

  • Investors AEW Capital Management and Newcastle Investment Corp. value the senior housing market at more than $300 billion.
  • Senior housing defined is “…a mix of real estate, hospitality, and care,” with high-quality housing and nursing care facilities presenting alternatives for the senior population, from choice-based options (independent living) in early retirement to needs-based (assisted living, memory care, and skilled nursing) as care requirements increase.
  • Nursing care, defined as skilled nursing facilities, nursing homes, and hospice centers, is estimated at more than $128 billion
  • The National Center for Health Statistics estimates expenditures for “long-term care services” between $210 and $306 billion, which include a variety of settings: in the home from a home health agency, adult day services centers, residential settings from assisted living communities, or in institutions from nursing homes.
  • A massive demographic shift or “silver tsunami” is underway in the United States which will see the older population double to 70 million people by 2030—up from 40 million in 2010—when more than twenty percent of the U.S. population will be over the age of 65